ProfileGDS5822 / ILMN_1258084
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 28% 7% 21% 6% 38% 30% 63% 16% 13% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 114.828
GSM1276600PDAC Late Ablation Control 210.67
GSM1276601PDAC Late Ablation Control 3721
GSM1276602PDAC Late Ablation 17.76
GSM1276603PDAC Late Ablation 217.738
GSM1276604PDAC Late Ablation 315.530
GSM1303940PDAC Late Ablation_anti-CTLA4 131.863
GSM1303941PDAC Late Ablation_anti-CTLA4 29.416
GSM1303942PDAC Late Ablation_anti-CTLA4 37.813